Primate Heart Regeneration
灵长类动物心脏再生
基本信息
- 批准号:9246569
- 负责人:
- 金额:$ 87.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2020-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAnimal ModelAnimalsArchitectureArrhythmiaBlood flowCardiacCardiac MyocytesCathetersCell Culture TechniquesCell DeathCell ProliferationCellsCessation of lifeChronicClinical TrialsCoronaryCoronary CirculationCoupledCouplingDoseElectric StimulationElectrocardiogramElectrophysiology (science)FerritinFoundationsGoalsGraft EnhancementsHeartHeart TransplantationHistologicHistologyHumanHypertrophyHypoxiaImageImaging TechniquesImmune responseIn SituInfarctionInjection of therapeutic agentIschemiaLeft ventricular structureLongitudinal StudiesMRI ScansMacacaMacaca nemestrinaMagnetic Resonance ImagingMapsModelingMonitorMorphologyMusMuscleMyocardial InfarctionMyocardial dysfunctionMyocardiumPacemakersPatientsPopulationPopulation DynamicsPositron-Emission TomographyPredispositionPrimatesPumpResearchStructureSystemTechnologyTelemetryTestingTimeTissuesTranslatingTransplantationTreatment EfficacyVascularizationVentricularVentricular ArrhythmiaVentricular DysfunctionVentricular FunctionWorkangiogenesisarterial remodelingbasecardiac regenerationclinically relevantdensitydesignefficacy studyexperimental studygraft healingheart rhythmhuman embryonic stem cellhuman pluripotent stem cellimprovedinsightinstrumentmicroangiographymolecular imagingnonhuman primateoverexpressionpreventpublic health relevancerepairedresponsetherapeutic evaluationvoltage
项目摘要
DESCRIPTION (provided by applicant): The long term goal of these studies is to develop a heart regeneration strategy that can be translated to humans. Our current focus is in human pluripotent stem cells, and more specifically, in human embryonic stem cell-derived cardiomyocytes (hESC-CMs). Building on 15 years' work in cell culture and small animals, we recently showed that hESC-CMs can be produced at a scale and purity that permit testing in the animal most likely to predict the human response: the non-human primate Macaca nemestrina. The hESC-CMs can generate grafts that average 40% of infarct size, and they electromechanically couple, beat in sync with the macaque heart and mature to adult size by 3 months. This proposal addresses the next-level challenges. Aim 1 is a pivotal efficacy study that will determine if hESC-CMs enhance contractile function in the infarcted macaque heart. Three doses of human cardiomyocytes will be tested, and ventricular structure and function will be determined by MRI. Aim 2 addresses the genesis of ventricular arrhythmias identified in our recent study. In addition to monitoring heart rhythm by telemetry, we will perform serial catheter-based mapping of the engrafted (3 cell doses) and sham-engrafted primate heart, generating activation maps that will classify arrhythmias as resulting from reentry or ectopic pacemakers. Programmed electrical stimulation will assess susceptibility to induced arrhythmias. In combination with Aim 1, these studies will determine if there is a dose of cardiomyocytes that enhances function without arrhythmias. Aim 3 uses molecular imaging techniques to assess graft population dynamics, tracking the waves of cell death and proliferation after transplantation. We also address the key question of graft vascularization, testing the hypothesis that grafts induce host coronary arterial remodeling and that, despite this response, that grafts are chronically underperfused. These experiments will provide the foundation for a planned clinical trial of heart repair and provide mechanistic insights not possible in human patients.
描述(由申请人提供):这些研究的长期目标是开发一种可用于人类的心脏再生策略。我们目前的重点是在人类多能干细胞,更具体地说,在人类胚胎干细胞衍生的心肌细胞(hESC-CM)。基于15年的细胞培养和小动物工作,我们最近表明,hESC-CM可以以一定的规模和纯度生产,允许在最有可能预测人类反应的动物中进行测试:非人灵长类动物Macaca nemestrina。hESC-CM可以产生平均40%梗死面积的移植物,它们机电耦合,与猕猴心脏同步跳动,并在3个月内成熟到成人大小。这一提议解决了下一级的挑战。目的1是一项关键的疗效研究,将确定hESC-CM是否增强梗塞猕猴心脏的收缩功能。将测试三种剂量的人心肌细胞,并通过MRI确定心室结构和功能。目的2解决了我们最近研究中发现的室性心律失常的起源。除了通过遥测监测心律外,我们还将对植入(3个细胞剂量)和假植入灵长类动物心脏进行连续的基于导管的标测,生成激动标测图,将心律失常分类为折返或异位起搏器所致。程控电刺激将评估诱发心律失常的易感性。结合目标1,这些研究将确定是否有一定剂量的心肌细胞可以增强功能而不发生心律失常。目的3:利用分子成像技术来评估移植物群体动态,跟踪移植后细胞死亡和增殖的波动。我们还讨论了移植物血管化的关键问题,测试移植物诱导宿主冠状动脉重塑的假设,尽管有这种反应,移植物是慢性灌注不足。这些实验将为计划中的心脏修复临床试验提供基础,并提供在人类患者中不可能实现的机制见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles E Murry其他文献
Regenerating the heart
再生心脏
- DOI:
10.1038/nbt1117 - 发表时间:
2005-07-01 - 期刊:
- 影响因子:41.700
- 作者:
Michael A Laflamme;Charles E Murry - 通讯作者:
Charles E Murry
Charles E Murry的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles E Murry', 18)}}的其他基金
Function, composition, and mechanism of RNA splicing factories in cardiomyopathy
RNA剪接工厂在心肌病中的功能、组成和机制
- 批准号:
10583011 - 财政年份:2022
- 资助金额:
$ 87.13万 - 项目类别:
Metabolic and Transcriptional Reprogramming of Cardiac Maturation
心脏成熟的代谢和转录重编程
- 批准号:
10202988 - 财政年份:2021
- 资助金额:
$ 87.13万 - 项目类别:
Metabolic and Transcriptional Reprogramming of Cardiac Maturation
心脏成熟的代谢和转录重编程
- 批准号:
10579257 - 财政年份:2021
- 资助金额:
$ 87.13万 - 项目类别:
Metabolic and Transcriptional Reprogramming of Cardiac Maturation
心脏成熟的代谢和转录重编程
- 批准号:
10378094 - 财政年份:2021
- 资助金额:
$ 87.13万 - 项目类别:
Project 4: UW-CNOF Biological Model Development and Data Generation
项目 4:UW-CNOF 生物模型开发和数据生成
- 批准号:
9021415 - 财政年份:2015
- 资助金额:
$ 87.13万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 87.13万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 87.13万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 87.13万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 87.13万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 87.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 87.13万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 87.13万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 87.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 87.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 87.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)